REmote Web Assisted Care for Heart Failure Patients With Implantable Cardioverter Defibrillators (REACH-ICD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01589913
Recruitment Status : Active, not recruiting
First Posted : May 2, 2012
Last Update Posted : August 3, 2018
University of Wuerzburg
Campus Bad Neustadt
Hospital Rothenburg ob der Tauber
University Hospital Brandenburg
Klinikum Aschaffenburg-Alzenau
Klinikum Bad Woerishofen
University of Leipzig
Information provided by (Responsible Party):
Wuerzburg University Hospital

Brief Summary:

Aim and Background: Although implantable cardioverter defibrillators (ICD) save lives, many ICD-patients experience psychosocial complications such as anxiety disorders, depression and reduced quality of life after ICD-implantation. A recent review has indicated great potential for psychosocial interventions to reduce anxiety and to increase exercise capacity of ICD-patients. In a previous study, the investigators showed that mailed information about technical, medical and psychological effects of ICD plus phone counseling are effective interventions for reducing anxiety, psychological distress and increasing QoL in ICD-patients < 65 years. In a pilot study the investigators also documented promising effects of an internet based intervention with similar content.

Method: In a prospective, multicenter, multidisciplinary, half-open, part-randomized, controlled clinical trial N = 200 patients with an ICD will either receive medical care as usual or additionally attend a psychosocial prevention program via remote care. Psychosocial support will be provided utilizing the advantages of the internet. Thus, patient-centered support will be offered independent from time and location.

Outcome measures are psychometric data (questionnaires on cardiac fear, etc.), cardiac functioning, and clinical status which will be assessed up to 1 week before ICD-implantation (T0), in week 1 (T1) and within one week after (T2) the 6-weeks prevention program, and 12 months after T0 (T3). Furthermore, demographic data, personality characteristics, expectations, physiology, pro-inflammatory cytokines and cardiac status will be assessed as mediating or moderating variables.

Hypotheses: A web-based psychosocial intervention in addition to medical care as usual leads to increased QoL and reduced anxiety and depression. Secondary goals are the identification of psychosocial and medical predictors, mediators, and moderators of treatment efficacy. Moreover, differences between patients with ICDs implanted for primary vs. secondary prevention will be explored.

Conclusion: This project will evaluate the feasibility and efficacy of an internet based intervention for ICD-patients. Furthermore, the investigators aim at identifying predictors and mediators of treatment outcome. This will improve interdisciplinary care for ICD-patients; further applications for other cardiovascular disorders as well as preventive programs for heart failure seem possible.

Condition or disease Intervention/treatment Phase
Anxiety Depression Quality of Life Behavioral: ICD-Forum Not Applicable

Detailed Description:
See Summary.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 118 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Remote Care for Reducing Cardiac Fear, Fear of Dying, Depression, and Increasing Quality of Life in ICD‐Patients With Cardiac Insufficiency/at Risk for Fatal Cardiac Arrhythmia.
Study Start Date : May 2012
Actual Primary Completion Date : July 2015
Estimated Study Completion Date : December 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Treatment as usual plus remote care
The same treatment as described under "treatment as usual" plus participation in the intervention "ICD-Forum".
Behavioral: ICD-Forum

The CBT based internet program ICD-Forum is designed to increase QoL, and decrease anxiety and depression in ICD-patients. The program includes a therapist moderated asynchronous discussion group and content focused modules following a six weeks schedule:

  1. Introduction to participants and online system
  2. Knowledge regarding ICDs
  3. Strategies for behavior change
  4. Psychological models for anxiety and depression
  5. Strategies to cope with avoidance, anxiety and depression
  6. Resume, evaluation, resolution of open questions, goal setting, good bye
Other Names:

No Intervention: Treatment as usual
Standard information provided by hospitals on ICD-technology as well as consequences of ICD-implantation plus medical aftercare including cardiology appointments at 1, 3, and 6 months, and one year after ICD-implantation.

Primary Outcome Measures :
  1. change of psychosocial well-being (combined score for measures of anxiety, depression, and quality of life) from week 1 (T1) to one week after (T2) the 6-weeks prevention program [ Time Frame: up to 1 week before ICD-implantation (T0), in week 1 (T1) and within one week after (T2) the 6-weeks prevention program, and 12 months after T0 (T3) ]
    assessment tools for aspects of psychosocial well-being (German versions will be used): Anxiety: Cardiac Fear Questionnaire (Hoyer & Eifert, 2001); Depression: Hospital Anxiety and Depression Scale (Hinz & Brähler, 2011); QoL: MOS 36-item short-form health survey (Ware & Sherbourne, 1992)

Secondary Outcome Measures :
  1. 1. Health status 2. ICD-related trauma 3. Life-style factors 4. ICD-Related concerns 5. Psychological well-being 6. Type-D personality 7. Social support 8. Economic efficiency [ Time Frame: up to 1 week before ICD-implantation (T0), in week 1 (T1) and within one week after (T2) the 6-weeks prevention program, and 12 months after T0 (T3) ]
    1. assessed by NYHA-class, LVEF, blood pressure
    2. measured through IES, Maercker, & Schützwohl, 1998 and PDEQ, Fuglsang, Moergeli, et al., 2002 and FSAS, Kuhl, et al., 2006
    3. measured through smoking, BMI
    4. measured through FPAS, Burns,, 2005 and ICD-Safety and Concerns Scales, Crössmann, 2005
    5. measured through SCL-9-K, Klaghofer & Brähler, 2001
    6. measured through DS14, Grande, et al., 2004
    7. measured through BSSS, Schulze, & Schwarzer, 2003
    8. measured according to Schweikert, Hahmann & Leidl, 2008

  2. psychophysiological parameters: heart rate variability [ Time Frame: up to 1 week before ICD-implantation (T0) and 1, 3, 6, and 12 months after ICD-implantation ]
    time- and frequency domain parameters of HRV (Camm et al., 1996)

  3. biometric markers: 1. proinflammatory cytokines 2. coagulation parameters [ Time Frame: up to 1 week before ICD-implantation (T0) and 6 months after ICD-implantation ]
    1. ELISA analysis of IL-1β, IL-6, TNF-α
    2. Fibrinogen

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Implanted ICD
  • Internet access can be installed during completion of the prevention program

Exclusion Criteria:

  • Medical reasons preventing participation of the prevention program (e.g. emergency hospitalization) for more than one week of the program
  • Suicidality (Patients with scores > 8 on the depression subscale of the HADS will be assessed via interviews conducted by a qualified psychologist)
  • Severe cognitive impairment (< 17 points in the MMST; Kessler, J., Markowitsch, H. J. & Denzler, P. (2000). Mini-Mental-Status-Test (MMST). Göttingen: Beltz Test GMBH. [Deutsche Adaption])
  • Insufficient command of German to follow the intervention program
  • Current ICD-10 diagnosis:
  • F1x: Mental and behavioral disorders due to psychoactive substance use
  • F2x: Schizophrenia, schizotypal and delusional disorders
  • F30: Manic Episode
  • F31: Bipolar affective disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01589913

Klinik Bad Wörishofen
Bad Wörishofen, Bavaria, Germany, 86825
Department of Cardiology, Center of Cardiovascular Medicine
Bad Neustadt An Der Saale, BY, Germany, 97616
Department of Internal Medicine, Krankenhaus Rothenburg ob der Tauber
Rothenburg ob der Tauber, BY, Germany, 91541
University of Wuerzburg
Wuerzburg, BY, Germany, 97070
Wuerzburg University Hospital, Department of Medicine I (Cardiology)
Wuerzburg, BY, Germany, 97080
Klinikum Aschaffenburg-Alzenau
Aschaffenburg, Hessen, Germany, 63739
Klinik für Kardiologie und Pulmologie, Medizinische Hochschule Brandenburg
Brandenburg, Germany, 14770
Sponsors and Collaborators
Wuerzburg University Hospital
University of Wuerzburg
Campus Bad Neustadt
Hospital Rothenburg ob der Tauber
University Hospital Brandenburg
Klinikum Aschaffenburg-Alzenau
Klinikum Bad Woerishofen
University of Leipzig
Principal Investigator: Paul Pauli, Prof. Dr. University of Würzburg
Principal Investigator: Stefan M Schulz, Dr. University of Würzburg

Additional Information:
Responsible Party: Wuerzburg University Hospital Identifier: NCT01589913     History of Changes
Other Study ID Numbers: UKW-CHFC-G2
First Posted: May 2, 2012    Key Record Dates
Last Update Posted: August 3, 2018
Last Verified: August 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Wuerzburg University Hospital:
Implantable Cardioverter Defibrillators
Heart Failure
Quality of Life
Remote Care

Additional relevant MeSH terms:
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders